Phase II CONDOR Trial suggests tolerance of inhibitor durvalumab in patients with metastatic head cancer Read more
Quidel seeks 510 (k) Clearance for QuickVue Influenza A+B Test complying FDA’s Class II RIDT Requirements Read more
SpinalCyte’s CybroCell Dermal Fibroblasts signals positive Phase 1/2 Clinical Trial Results Read more
MOLOGEN forays into global co-development agreement with ONCOLOGIE for lead compound lefitolimod Read more
Merck overturns APECS Study assessing Verubecestat (MK-8931) for Prodromal Alzheimer’s Disease Read more